CLARITY MEDICAL (01406) has released its annual results for the fiscal year ended March 31, 2025, showing a 5.4% decline in revenue to approximately HK$181 million.
The company recorded a net loss of HK$34.289 million, representing a significant 54.8% narrowing compared to the previous year.
Loss per share stood at 6.5 HK cents for the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.